NOI to Sole Source PhysioMimix Organ-on-a-Chip systems
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Defense Health Agency Contracting Activity (DHACA), on behalf of the United States Army Medical Research Institute of Infectious Diseases (USAMRIID), intends to award a Firm Fixed Price, sole source Indefinite Delivery Indefinite Quantity (IDIQ) contract to CN Bio Innovations Limited. This notice is for the procurement of PhysioMimix Organ-on-a-Chip systems and compatible consumables. The government asserts that CN Bio Innovations Limited is the only vendor capable of meeting the specific compatibility requirements with existing USAMRIID systems. This is a Special Notice and not a Request for Quotations (RFQ).
Scope of Requirement
The requirement is for the delivery of PhysioMimix Organ-on-a-Chip systems and associated consumables/components. These must be fully compatible with the existing PhysioMimix systems currently in use at USAMRIID. The justification for sole source is based on the proprietary nature of CN Bio's consumables, which are essential for compatibility with the current transwell-based organoid models at USAMRIID. The place of performance is Frederick, MD.
Contract & Timeline
- Type: Firm Fixed Price, Sole Source IDIQ
- Authority: 41 USC 1901, FAR 12.102, FAR 12.201-1
- Set-Aside: None specified (Sole Source)
- Product Service Code: 6640 (Laboratory Equipment And Supplies)
- Published: April 17, 2026
Action for Industry
This notice is not a solicitation. However, vendors who believe they can challenge the sole source basis must submit a capability statement. This statement must include sufficient detail and convincing evidence demonstrating the ability to provide the required supplies, meeting the government's minimum essential characteristics and compatibility with existing CN Bio PhysioMimix systems. Submissions that only ask questions will not be considered.
Deadlines & Submission
- Capability Statements Due: May 5, 2026, by 10:00 AM Eastern Time.
- Submission Method: Email ONLY as a Microsoft Word or Adobe PDF attachment to grant.a.gratton.civ@health.mil and jayme.l.fletcher2.civ@health.mil.
- Contact: Grant A. Gratton (grant.a.gratton.civ@health.mil) or Jayme Fletcher (jayme.l.fletcher2.civ@health.mil). No phone calls will be accepted.